OR WAIT null SECS
June 19, 2024
PRAC is reviewing the risk of secondary malignancies in patients treated with CAR T-cell medicines.
June 12, 2024
CordenPharma has partnered with Spain-based Certest to develop ionizable lipids for LNP formulations.
The completed expansion at AGC Biologics'Copenhagen, Denmark, site, doubles the company's single-use bioreactor capacity for mammalian-based services.
June 04, 2024
The political landscapes of both the EU and UK are set to change after the latest elections, which could affect the bio/pharma industry.
CGT Catapult and CATTI aim to standardize advanced therapy manufacturing with new aligned training standards.
June 01, 2024
CGT Catapult will implement Cellular Origins' robotic platform in its Stevenage, UK, site to establish automated CGT manufacturing.
May 24, 2024
With this acquisition, Merck KGaA will have the capability to offer integrated services for viral vector manufacturing.
May 20, 2024
After a review, the agency concluded there was a possible risk of cancer to those exposed to 17-hydroxyprogesterone caproate in the womb.
May 13, 2024
EMA’s CHMP recommended treatments for hemophilia A, colorectal cancer, hypertension, overactive bladder, and metastatic breast cancer.
April 29, 2024
The non-profit initiative puts collaboration at the forefront as it tackles the challenges surrounding recycling primary pharmaceutical packaging.